Loading ETF profile…
Command Palette
Search for a command to run...
Search for a command to run...
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| ABBV | AbbVie Inc | 5.64% | $24.11M |
| ABT | Abbott Laboratories | 5.38% | $23.03M |
| AMGN | Amgen Inc | 5.22% | $22.34M |
| LLY | Eli Lilly & Co | 5.18% | $22.18M |
| JNJ | Johnson & Johnson | 5.13% | $21.93M |
| MRK | Merck & Co Inc | 5.03% | $21.53M |
| GILD | Gilead Sciences Inc | 4.81% | $20.59M |
| PFE | Pfizer Inc | 4.59% | $19.64M |
| CORT | Corcept Therapeutics Inc | 3.95% | $16.89M |
| AMRX | Amneal Pharmaceuticals Inc | 3.74% | $16.03M |
| LGND | Ligand Pharmaceuticals Inc | 3.35% | $14.32M |
| LQDA | Liquidia Corp | 3.33% | $14.23M |
| TVTX | Travere Therapeutics Inc | 3.31% | $14.18M |
| HRMY | Harmony Biosciences Holdings Inc | 2.96% | $12.66M |
| OCUL | Ocular Therapeutix Inc | 2.94% | $12.56M |
| BIIB | Biogen Inc | 2.87% | $12.29M |
| COLL | Collegium Pharmaceutical Inc | 2.85% | $12.20M |
| REGN | Regeneron Pharmaceuticals Inc | 2.84% | $12.16M |
| VTRS | Viatris Inc | 2.83% | $12.11M |
| PBH | Prestige Consumer Healthcare Inc | 2.80% | $11.97M |
| BMY | Bristol-Myers Squibb Co | 2.77% | $11.85M |
| — | Perrigo Co PLC | 2.74% | $11.74M |
| JAZZ | Jazz Pharmaceuticals PLC | 2.71% | $11.59M |
| SUPN | Supernus Pharmaceuticals Inc | 2.68% | $11.47M |
| ANIP | ANI Pharmaceuticals Inc | 2.67% | $11.43M |